Thank you, Mr. Chair.
Thank you, Medicines New Zealand.
In your view, what types of pharmaceutical pricing and/or reimbursement strategies are necessary to promote innovation in the development of new medicines while ensuring the financial sustainability of prescription drug coverage programs?